Travere Therapeutics to Present at Upcoming Investor Conferences
February 22 2021 - 4:30PM
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that
Company management will present at the following upcoming virtual
investor conferences in February and March:
SVB Leerink 10th Annual Global Healthcare
ConferenceDate: Wednesday, February 24,
2021Time: 1:00 p.m. ET
Barclays Global Healthcare
ConferenceDate: Wednesday, March 10,
2021Time: 11:30 a.m. ET
Live webcasts will be available at
https://ir.travere.com/events-presentations and archived replays
will be accessible for up to 30 days.
About Travere Therapeutics
At Travere Therapeutics we are in rare for life.
We are a biopharmaceutical company that comes together every day to
help patients, families and caregivers of all backgrounds as they
navigate life with a rare disease. On this path, we know the need
for treatment options is urgent – that is why our global team works
with the rare disease community to identify, develop and deliver
life-changing therapies. In pursuit of this mission, we
continuously seek to understand the diverse perspectives of rare
patients and to courageously forge new paths to make a difference
in their lives and provide hope – today and tomorrow. For more
information, visit travere.com
Contact:Chris Cline,
CFA
Senior Vice
President, Investor Relations & Corporate
Communications888-969-7879 IR@travere.com
Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Sep 2023 to Sep 2024